Literature DB >> 3973901

Synthesis and antiarrhythmic and parasympatholytic properties of substituted phenols. 3. Modifications to the linkage region (region 3).

D M Stout, W L Matier, C Barcelon-Yang, R D Reynolds, B S Brown.   

Abstract

As part of a continuing program of systematically modifying the structure of the class I antiarrhythmic drug changrolin, we synthesized 15 analogues in which the linkage between the two aromatic regions was altered. High antiarrhythmic activity and low parasympatholytic activity was found when the linkage region, designated region 3, contained a carbonyl moiety, including ketones, amides, and ureas. Secondary amides were superior to tertiary amides, while amide reversal resulted in no change in activities. One compound in this series, 7, 2,6-bis(1-pyrrolidinyl-methyl)-4-benzamidophenol (ACC-9358), is undergoing preclinical evaluations.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3973901     DOI: 10.1021/jm00381a006

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  5 in total

1.  Comparison of the parasympatholytic activity of ACC-9358 and disopyramide.

Authors:  B S Brown; R J Gorczynski; R D Reynolds; J E Shaffer
Journal:  Br J Pharmacol       Date:  1986-01       Impact factor: 8.739

2.  Discovery of N-(3,5-bis(1-pyrrolidylmethyl)-4-hydroxybenzyl)-4-methoxybenzenesulfamide (sulcardine) as a novel anti-arrhythmic agent.

Authors:  Dong-Lu Bai; Wei-Zhou Chen; Yun-Xin Bo; Yue-Li Dong; Ai-Li Kang; Wei-Kang Sun; Wei Wang; Zhong-Liang Hu; Yi-Ping Wang
Journal:  Acta Pharmacol Sin       Date:  2012-08-27       Impact factor: 6.150

3.  Docking Studies of Methylthiomorpholin Phenols (LQM300 Series) with Angiotensin-Converting Enzyme (ACE).

Authors:  Víctor H Vázquez-Valadez; V H Abrego; Pablo A Martínez; Gabriela Torres; Oscar Zúñiga; Daniel Escutia; Rebeca Vilchis; Ana Ma Velázquez; Luisa Martínez; Mónica Ruiz; Brígida Camacho; Rafael López-Castañares; Enrique Angeles
Journal:  Open Med Chem J       Date:  2013-11-23

4.  Discovery of Potent VEGFR-2 Inhibitors based on Furopyrimidine and Thienopyrimidne Scaffolds as Cancer Targeting Agents.

Authors:  Marwa A Aziz; Rabah A T Serya; Deena S Lasheen; Amal Kamal Abdel-Aziz; Ahmed Esmat; Ahmed M Mansour; Abdel Nasser B Singab; Khaled A M Abouzid
Journal:  Sci Rep       Date:  2016-04-15       Impact factor: 4.379

5.  Design, synthesis and biological evaluation of a new thieno[2,3-d]pyrimidine-based urea derivative with potential antitumor activity against tamoxifen sensitive and resistant breast cancer cell lines.

Authors:  Marwa Sharaky; Marwa Kamel; Marwa A Aziz; Mervat Omran; Monira M Rageh; Khaled A M Abouzid; Samia A Shouman
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.